Background: About 500 new smear-positive Multidrug-resistant tuberculosis (MDR-TB) cases are estimated to occur per year in Uganda. In 2008 in Kampala, MDR-TB prevalence was reported as 1.0% and 12.3% in …
BACKGROUND: Antiretroviral therapy (ART) management is challenging for individuals in resource-limited settings presenting for third-line treatment because of complex resistance patterns, partly due to reduced access to viral load monitoring. …
governments to save lives and reduce the burden of disease. This annual report summarized progress that CHAI made in 2015 toward achieving our mission. CHAI was founded with a goal …
The increased penetration of mobile devices has created opportunities in the health sector and led to emerging of mobile health systems. As much as the mobile health systems have registered …
Introduction Interventions informed by behaviouraleconomics, such as planning prompts, have the potentialto increase HIV testing at minimal or no cost. Planningprompts have not been previously evaluated for HIVtesting uptake. We …
We examined the relationships between home blood pressure (BP) and atmospheric temperature in 20 treated-hypertensive patients. A significant correlation between morning and evening BP and atmospheric temperature was found. For …
Background: Influenza surveillance helps time prevention and control interventions especially where complex seasonal patterns exist. We assessed influenza surveillance sustainability in Africa where influenza activity varies and external funds for …
Background: Data on physical inactivity, a known risk factor for noncommunicable diseases and its correlates in sub-Saharan Africa are almost absent. We assessed physical activity patterns and associated factors among …
Background. There is controversy on the association between socioeconomic status (SES) and HIV infection. Some evidence claimshigher SES is negatively associated with HIV infection while others report the reverse. Objectives. …
BACKGROUND AND AIMS: Major adverse cardiac events (MACE) remain a leading cause of mortality in chronic kidney disease (CKD). Apabetalone is an orally available inhibitor of bromodomain & extraterminal (BET) …